Recombinant antigens as components of a diphtheria-tetanus-pertussis vaccine.
Makoff
A J
AJ
Department of Cell Biology, Wellcome Foundation Ltd., Beckenham, Kent, United Kingdom.
Charles
I G
IG
Fairweather
N F
NF
D000942:Antigens, Bacterial / Q000096:biosynthesis* / Q000235:genetics; D001425:Bacterial Outer Membrane Proteins / Q000096:biosynthesis / Q000235:genetics; D003001:Cloning, Molecular; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000096:biosynthesis*; D010446:Peptide Fragments / Q000096:biosynthesis / Q000235:genetics; D012441:Saccharomyces cerevisiae / Q000235:genetics; D012475:Salmonella / Q000235:genetics; D013744:Tetanus Toxin / Q000096:biosynthesis / Q000235:genetics; D014614:Vaccines, Synthetic / Q000096:biosynthesis*; D010566:Virulence Factors, Bordetella
D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D010446:Peptide Fragments; D013744:Tetanus Toxin; D014614:Vaccines, Synthetic; D010566:Virulence Factors, Bordetella; C040635:tetanus toxin fragment C; C068929:pertactin